In this context, it is, however, noteworthy that the upregulation of the circulating levels of hepcidin is not a hallmark of all cancers because the serum levels of hepcidin are reduced in patients with nasopharyngeal carcinoma as well as in patients with hepatocellular carcinoma [25,26,27]. Here, HAMP is linked to hepatocellular carcinoma.